FDA
-
-
-
-
-
-
-
Cosmos Health projects $3.2M revenue from Fort18 supplement launch
-
-
-
-
-
-
-
Cosmos Health reports no Middle East conflict impact, targets $12M US revenue
-
-
-
-
-
-
-
Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position U
-
-
-
-
-
-
-
Cosmos Holdings Launches Mosept-Oral Antiseptic Spray Designed to be Effective Against Bacteria and Certain Viral Pathogens
-
325,994 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

